Clinical effect and safety of cyclin-dependent kinase 4/6 inhibitors on the treatment of hormone receptor positive and human epidermal growth factor receptor-2 negative advanced breast cancer

Gu Yuanyuan; Zhang Xiaojing; Yang Lei; Guan Yin

doi:10.3760/j.issn.1673-4777.2022.06.016

Home>Articles>Clinical effect and safety of cyclin-dependent kinase 4/6 inhibitors on the treatment of hormone receptor positive and human epidermal growth factor receptor-2 negative advanced breast cancer

DOI: 10.3760/j.issn.1673-4777.2022.06.016

Clinical effect and safety of cyclin-dependent kinase 4/6 inhibitors on the treatment of hormone receptor positive and human epidermal growth factor receptor-2 negative advanced breast cancer

Gu Yuanyuan

Zhang Xiaojing

Yang Lei

Guan Yin

Machine-generated Keywords：

Publication Date：2022-06-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：4( 867-870 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2022,17(6)